# Mifepristone 2.5, 5, 10 mg Versus Placebo in the Treatment of Endometriosis

> **NCT02271958** · PHASE2,PHASE3 · COMPLETED · sponsor: **Mediterranea Medica S. L.** · enrollment: 360 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Mifepristone
- **DRUG:** PLACEBO

## Key facts

- **NCT ID:** NCT02271958
- **Lead sponsor:** Mediterranea Medica S. L.
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2013-10
- **Final completion:** 2013-12
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2014-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02271958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02271958, "Mifepristone 2.5, 5, 10 mg Versus Placebo in the Treatment of Endometriosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02271958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*